Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-27T18:49:59.193Z Has data issue: false hasContentIssue false
  • English
  • Français

What The Research Says . . . In One Line

Published online by Cambridge University Press:  02 May 2013

Mohamad Haniki Nik Mohamed
Mohamad Haniki Nik Mohamed*
Affiliation:
International Islamic University Malaysia, Kuantan, Malaysia
Get access Rights & Permissions [Opens in a new window]

Extract

Carbon monoxide-validated four-week smoking abstinence from 167,487 treatment episodes among patients from 42 UK National Health Service Stop Smoking Services (1 April 2009, to 30 June 2011) showed smoking abstinence rates were higher with varenicline than combination nicotine replacement therapy (43.5% vs. 36.9%) but systematic variation in medication effect across clinical services and differences in predictors of outcome between medications resulted in a small mean advantage for varenicline (odds ratio, 1.080; 95% CI, 1.003–1.163; difference, 1.86%; 95% CI, 0.07%–3.67%; P = .04).

Type
Regular Feature
Information
Journal of Smoking Cessation , Volume 8 , Issue 1 , June 2013 , pp. 60 - 61
Copyright
Copyright © The Authors 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)